The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Polar Capital Funds PLC & Others
NEPHROPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Polar Capital Funds PLC, along with its two PAC funds (Emerging Markets Healthcare Fund and Healthcare Discovery Fund), bought 214,331 shares (0.214%) of Nephrocare Health Services on 19 December 2025 through the open market. This takes their combined holding from 4.843% to 5.057%, crossing the 5% SEBI disclosure threshold under Regulation 29(1). The acquirer is not a promoter but a foreign institutional investor based in London. Total equity share capital of the company remains unchanged at 10,03,40,717 shares. The acquisition signals continued FII interest in this healthcare services stock.
The crossing of the 5% mark by a global healthcare-focused fund like Polar Capital is a mild positive signal, suggesting institutional confidence in the stock. Retail investors should note potential further buying up to the next regulatory threshold of 10%, which could support price action.